CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 28.40
-0.20 (-0.70%)
Apr 10, 2025, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 10.38 billion as of April 10, 2025. Its market cap has increased by 11.10% in one year.
Market Cap
10.38B
Enterprise Value
9.12B
Revenue
900.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.40
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 10.38B, an increase of 37.07%. That is a compound annual growth rate of 5.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 184.30B |
| Hansoh Pharmaceutical Group Company | 127.29B |
| JD Health International | 91.83B |
| WuXi Biologics | 73.02B |
| Innovent Biologics | 68.89B |
| Alibaba Health Information Technology | 63.36B |
| Sino Biopharmaceutical | 61.23B |
| Sichuan Kelun-Biotech Biopharmaceutical | 58.91B |